- Elder Pharmaceuticals net profit rises 7.71% in the March 2013 quarter 15 May | 09:26 AM
Net profit of Elder Pharmaceuticals rose 7.71% to Rs 18.44 crore in the quarter ended March 2013 as against Rs 17.12 crore during the previous
- Elder Pharma tanks 45.7% in 5 days 14 May | 11:44 AM
Meanwhile, the S&P BSE Sensex was up 85.73 points or 0.44% at 19,777.40. On BSE, 1.15 lakh shares were traded in the counter as against average daily
- Elder Pharma tumbles to 52-week low on sale of pledged shares 13 May | 12:37 PM
The company made the announcement during trading hours today, 13 May 2013.Meanwhile, the S&P BSE Sensex was down 172.12 points or 0.86% at
- Elder Pharmaceuticals to extend its financial year end 09 Mar | 11:05 AM
The board of Elder Pharmaceuticals have decided to extend the financial year 2012-13 by three months so as to end on 30 June 2013 instead of 31 March
- Elder Pharma jumps after inking JV with Japanese firm 07 Mar | 03:22 PM
The announcement was made after market hours on Wednesday, 6 March 2013.Meanwhile, the BSE Sensex was up 158.29 points, or 0.82%, to 19,410.90.On
- Elder Pharmaceuticals to create JV with KOSE Corporation of Japan 06 Mar | 04:00 PM
Elder Pharmaceuticals has announced that the company has finalized terms and conditions of joint venture agreement with KOSE Corporation, Japan for
- Elder Pharma off 5% in 2 days after muted Q3 earnings 18 Feb | 02:54 PM
Meanwhile, the BSE Sensex was up 45.18 points or 0.23% at 19,513.33.On BSE, 90,374 shares were traded in the counter as against average daily volume
- Elder Pharmaceuticals net profit declines 13.39% in the December 2012 quarter 16 Feb | 02:53 PM
Net profit of Elder Pharmaceuticals declined 13.39% to Rs 19.67 crore in the quarter ended December 2012 as against Rs 22.71 crore during the
- Elder Pharma drops on muted Q3 earnings 15 Feb | 12:02 PM
The company announced Q3 results after market hours on Thursday, 14 February 2013.Meanwhile, the BSE Sensex was down 69.71 points or 0.36% at
- Elder Pharmaceuticals signs MoU with Holding PharmEco 24 Dec | 01:50 PM
Elder Pharmaceuticals, one of the fastest growing pharmaceutical major in the country today (24 December 2012) signed a memorandum of understanding
- Elder Pharma gains after JV with Russian firm 24 Dec | 02:49 PM
The announcement was made during trading hours today, 24 December 2012.Meanwhile, the BSE Sensex was up 13.40 points, or 0.07%, to 19,255.40. On BSE,
- Elder Pharmaceuticals receives COS from EDQM for DIOSMIN API 06 Nov | 04:33 PM
Elder Pharmaceuticals has received the Certificate of Suitability (COS) from EDQM (European Directorate for the Quality of Medicines & Healthcare)
- Elder Pharmaceuticals` board decides to appoint additional director 03 Nov | 10:39 AM
The board of Elder Pharmaceuticals in its meeting on 02 November 2012 has decided to appoint James Mceuen as additional director of the
- Elder Pharmaceuticals net profit rises 20.72% in the September 2012 quarter 02 Nov | 07:56 PM
Elder Pharmaceuticals net profit rose 20.72% to Rs 27.03 crore in the quarter ended September 2012 as against Rs 22.39 crore during the previous
- Elder Pharma drops ex-dividend 17 Sep | 02:13 PM
Meanwhile, the BSE Sensex was up 132.48 points or 0.72% to 18,596.75.On BSE, 1,606 shares were traded in the counter as against average daily volume
- Elder Pharmaceuticals recommends dividend 10 Aug | 10:03 AM
The board of Elder Pharmaceuticals in its meeting on 09 August 2012 has recommended dividend at the rate of Rs 3 per share (30%).Powered by Capital
- Elder Pharmaceuticals` board approves scheme of arrangement 03 Aug | 10:40 AM
The Board of Elder Pharmaceuticals in its meeting on 02 August 2012 has approved the scheme of arrangement between the company and Elder Health Care
- Elder Pharmaceuticals to consider dividend 31 Jul | 06:06 PM
The board meeting of Elder Pharmaceuticals will be held on 09 August 2012 to consider and approve the unaudited provisional financial results of the
- Elder Pharmaceuticals to hold board meeting 31 Jul | 06:02 PM
The board meeting of Elder Pharmaceuticals will be held on 02 August 2012 to consider and explore various strategic growth options and opportunities
- Elder Pharmaceuticals net profit declines 5.99% in the March 2012 quarter 15 May | 09:35 PM
Net profit of Elder Pharmaceuticals declined 5.99% to Rs 17.12 crore in the quarter ended March 2012 as against Rs 18.21 crore during the previous